Cargando…

785 SARS-COV-2 INFECTS ENTEROCYTES IN VIVO AND CAN PERSIST UP TO 7 MONTHS FOLLOWING RESOLUTION OF SYMPTOMS

Detalles Bibliográficos
Autores principales:	Tokuyama, Minami, Ladinsky, Mark S., Jha, Divya, Cossarini, Francesca, Livanos, Alexandra E., Reidy, Jason, Tankelevich, Michael, Martinez-Delgado, Gustavo, Bjorkman, Pamela J., Mehandru, Saurabh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AGA Institute. Published by Elsevier Inc. 2021
Materias:	AGA Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108379/ http://dx.doi.org/10.1016/S0016-5085(21)01130-6

Ejemplares similares

1161: PERSISTENT IMMUNE CELL ABNORMALITIES IN THE INTESTINAL MUCOSA OF PATIENTS AFTER RECOVERY FROM COVID-19 INFECTION
por: Meringer, Hadar, et al.
Publicado: (2022)

Fr137 FIRST HIGH DIMENSIONAL EXAMINATION OF INTESTINAL BIOPSIES IN PATIENTS WITH COVID-19
por: Jha, Divya, et al.
Publicado: (2021)

Fr492 SIGNIFICANTLY REDUCED MORTALITY IN COVID-19 PATIENTS WITH GASTROINTESTINAL MANIFESTATIONS
por: Livanos, Alexandra E., et al.
Publicado: (2021)

782 PERSISTENT GASTROINTESTINAL SYMPTOMS AND CHRONIC FATIGUE AFTER SARS-COV-2 INFECTION.
por: Noviello, Daniele, et al.
Publicado: (2021)

Su083 PERSISTENCE OF GASTROINTESTINAL SYMPTOMS AFTER HOSPITALIZATION FOR COVID-19: PREVALENCE AND RISK FACTORS
por: Blackett, John W., et al.
Publicado: (2021)

Su1496: SARS-COV-2 INFECTION IN IBD: PANDEMIC WAVES AND PREDICTORS OF SEVERE OR PERSISTENT COVID-19
por: Taxonera, Carlos, et al.
Publicado: (2022)

1166: IN-PATIENT ANTIBIOTIC EXPOSURE PROMOTES SARS-COV-2 PERSISTENCE IN THE GI TRACT IN COVID-19 ADMITTED PATIENTS
por: Sharma, Ashok, et al.
Publicado: (2022)

Tu1553: SPECIFIC IMMUNOGLOBLIN A INDUCED BY THE PERSISTENT COLONIZATION OF ADHERENT-INVASIVE E.COLI LIMITS PATHOBINT LOCALIZATION TO THE EPITHELIAL NICHE
por: Imai, Jin, et al.
Publicado: (2022)

Fr093 COVID-19 PEDIATRIC PATIENTS IN THE UNITED STATES; AFRICAN AMERICAN AND HISPANIC AMONG MOST HOSPITALIZED PATIENTS WITH PERSISTENT GI MANIFESTATIONS
por: Ashktorab, Yusuf, et al.
Publicado: (2021)

Fr497 INCIDENCE AND OUTCOMES OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Khan, Shahab R., et al.
Publicado: (2021)

Su1488: WITHIN 6 MONTHS FROM COVID-19 BNT162B2 VACCINE PATIENTS WITH INFLAMMATORY BOWEL DISEASES TREATED WITH ANTI-TNFα HAVE SIGNIFICANTLY LOWER SEROLOGIC RESPONSES
por: Rabinowitz, Keren M., et al.
Publicado: (2022)

Su254 REDUCED ENDOSCOPY UTILIZATION FOR UPPER GASTROINTESTINAL BLEEDING DURING COVID-19 PANDEMIC: A MULTICENTER RESEARCH NETWORK STUDY
por: Goyal, Hemant, et al.
Publicado: (2021)

Fr003 TRUE PREVALENCE OF SARS-COV-2 INDUCED DIARRHEA AMONG YOUNG AND OLDER ADULTS: A MULTICENTER STUDY
por: Perisetti, Abhilash, et al.
Publicado: (2021)

Su1075: SIMILAR RISK OF INFECTION WITH SARS-COV-2 IN IMMUNOCOMPROMISED AND IMMUNOCOMPETENT PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND HEALTHY CONTROLS
por: Kante, Bhaskar, et al.
Publicado: (2022)

Fungal Planet description sheets: 785–867
por: Crous, P.W., et al.
Publicado: (2018)

AGA Institute Rapid Review and Recommendations on the Role of Pre-Procedure SARS-CoV-2 Testing and Endoscopy
por: Sultan, Shahnaz, et al.
Publicado: (2020)

AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19
por: Sultan, Shahnaz, et al.
Publicado: (2020)

AGA-Mitteilungen
Publicado: (2020)

AGA-Mitteilungen
Publicado: (2020)

Su1189 SAFETY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH PREEXISTING INFLAMMATORY BOWEL DISEASE AND MICROSCOPIC COLITIS
por: Grover, Shilpa, et al.
Publicado: (2020)

Su1187 ALMOST EVERYTHING CAUSES DIARRHEA: GASTROINTESTINAL MANIFESTATIONS OF ACUTE RESPIRATORY INFECTIONS AMONG 3,510 INDIVIDUALS IN A COMMUNITY-BASED STUDY
por: Newman, Kira L., et al.
Publicado: (2020)

AGA-Mitteilungen
Publicado: (2020)

Sa101 INCREASING THE LOW-RISK THRESHOLD FOR PATIENTS WITH UPPER GASTROINTESTINAL BLEEDING DURING THE COVID-19 PANDEMIC: A PROSPECTIVE, MULTICENTRE, FEASIBILITY STUDY
por: Dunne, Philip, et al.
Publicado: (2021)

Sa002 IMPACT OF THE COVID-19 PANDEMIC ON A LARGE ORGANIZED COLORECTAL CANCER SCREENING PROGRAM BASED ON FECAL IMMUNOCHEMICAL TESTING AND OPPORTUNISTIC COLONOSCOPY
por: Levin, Theodore R., et al.
Publicado: (2021)

Sa003 COVID-19 PANDEMIC AND REDUCTION OF COLORECTAL CANCER SCREENING RELATED PROCEDURES IN THE CZECH REPUBLIC
por: Suchanek, Stepan, et al.
Publicado: (2021)

Sa004 DECLINING COLORECTAL CANCER SCREENING IN THE AGE OF COVID-19
por: Torres, Jon Alexander, et al.
Publicado: (2021)

Fr089 IMPACT OF COVID-19 ON PANDEMIC MAJOR GASTROENTEROLOGY PROCEDURES, VISITS, AND NEW DIAGNOSIS OF GASTROINTESTINAL CANCERS
por: Khan, Ahmad, et al.
Publicado: (2021)

Sa504 INCIDENCE OF INFLAMMATORY BOWEL DISEASE IN SOUTH ASIAN AND CHINESE PEOPLE: A POPULATION-BASED COHORT STUDY FROM ONTARIO, CANADA
por: Dhaliwal, Jasbir, et al.
Publicado: (2021)

109 THE RISK ASSESSMENT OF NASOGASTRIC INTUBATION, A DAILY CLINICAL PRACTICE, DURING THE COVID-19 THREAT BY AEROSOL GENERATION AND DROPLET SPREAD
por: Verbeure, Wout, et al.
Publicado: (2021)

AGA-Mitteilungen
Publicado: (2021)

775f The Introduction of Faecal Immunochemical Testing as a Triaging Tool for Colorectal Cancer Investigation During the COVID-19 Pandemic. A Service Evaluation and Report.
por: Glover, Ben, et al.
Publicado: (2021)

Corneal Abrasions During Endoscopic Procedures in the COVID-19 Era Are a Preventable Phenomenon: A Quality Improvement Project
por: Haghighat, Shida, et al.
Publicado: (2021)

Improving Colorectal Cancer Screening and Polyp Surveillance During the COVID-19 Pandemic
por: Mujtaba, Sobia, et al.
Publicado: (2021)

Sa143 THE RISK OF COVID-19 IS HIGHER IN FEMALES USING PROTON PUMP INHIBITORS
por: Ghoneim, Sara, et al.
Publicado: (2021)

427 AEROSOL MODELING AND MITIGATION STRATEGIES
por: Jaruvongvanich, Veeravich, et al.
Publicado: (2021)

731 FAILURE TO DEVELOP NEUTRALIZING ANTIBODIES FOLLOWING SARS-COV-2 INFECTION IN YOUNG PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING BIOLOGICS
por: Dailey, Joelynn, et al.
Publicado: (2021)

Su093 GUT-BRAIN AXIS AND IRRITABLE BOWEL SYNDROME DURING SARS COV-2 PANDEMIC. A SURVEY BASED STUDY.
por: Piskorz, Maria, et al.
Publicado: (2021)

Fr001 PROTON PUMP INHIBITOR AND RISK OF SARS-COV-2 INFECTION: A MULTI-CENTER EXPERIENCE
por: Silverman, Anna L., et al.
Publicado: (2021)

Fr496 THE EFFECTS OF COMORBIDITIES ON COVID-19 OUTCOMES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Parekh, Rajen, et al.
Publicado: (2021)

Fr099 HEALTHCARE PROVIDER SATISFACTION WITH VIRTUAL CARE DELIVERY IN ALBERTA DURING THE COVID-19 PANDEMIC.
por: Olayinka, Lily, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e9oseht693q5v58r17nnub4mq2